Molecular Cytogenetics Market Size, Share, Growth Drivers, Industry Analysis and Application Forecas

From: MARKETSANDMARKETS
Published: Thu Sep 27 2018


According to a new market research report "Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) — Forecast to 2021", published by MarketsandMarkets.

The Molecular Cytogenetics Market report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the molecular cytogenetics market along with the estimates and forecasts of the revenue and market share analysis.

Browse 78 market data Tables and 47 Figures spread through 147 Pages and in-depth TOC on "Molecular Cytogenetics Market"
http://www.marketsandmarkets.com/Market-Reports/molecular-cytogenetic-market-148469224.html

The major factors driving the growth of this market are increasing incidence of genetic disorders and cancer, rapid growth in the aging population, and growing healthcare expenditure worldwide.

Molecular Cytogenetics Market, by Product & Service;

Kits and Reagents
Testing Kits
Probes
Fluorescent Affinity Reagents

The report segments this market based on product, technique, application, end user, and region. Among the products, kits and reagents are expected to account for the largest share of the market. The high growth of kits and reagents segment can be attributed to the increasing number of rental agreements and increasing use of kits and reagents in diagnosis of genetic disorders and cancer worldwide.

On the basis of techniques, the molecular cytogenetics market is segmented into comparative genomic hybridization, fluorescence in situ hybridization, in situ hybridization, and other techniques.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=148469224

Based on applications, the molecular cytogenetics market is segmented into genetic disorders, cancer, personalized medicine, and other applications. The genetic disorders segment is expected to account for the largest share of the global molecular cytogenetics market in 2016.

Molecular Cytogenetics Market, by Application;

Genetic Disorders
Cancer
Personalized Medicine

Based on end users, the molecular cytogenetics market is segmented into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global molecular cytogenetics market in 2016. Rise in healthcare expenditure has resulted in the increasing diagnosis of genetic disorder and cancer resulting in increasing use of cytogenetic kits and reagents in the above mentioned end users.

Molecular Cytogenetics Market, by End User;

Clinical and Research Laboratories
Academic Research Institutes
Pharmaceutical and Biotechnology Companies

Based on regions, the global molecular cytogenetics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in the aging population and increasing prevalence of cancer and genetic disorders in the region.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=148469224

Key players in the molecular cytogenetics market include F. Hoffmann-La Roche Ltd. (Switzerland) Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Gene Technology (U.K.), and Applied Spectral Imaging (U.S.).

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model — GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: sales@marketsandmarkets.com
Company: MARKETSANDMARKETS
Contact Name: 1marketsandmarkets
Contact Email: debashish.roy@marketsandmarkets.com
Contact Phone: +18886006441

Visit website »